Forest Laboratories, Inc. to Host Investor Meeting to Review Company’s Late-Stage Product Development Pipeline & Commercial...
April 17 2012 - 5:14PM
Business Wire
Forest Laboratories, Inc. (NYSE: FRX), an international
manufacturer and marketer of pharmaceutical products, today
announced that it will host a meeting on Wednesday, June 20, 2012
to review its late-stage product development pipeline and
commercialization strategy. The meeting will feature therapeutic
area presentations by senior leadership from the Forest Research
Institute, Inc., the Company’s research and development arm, and
product commercialization strategy by senior corporate executives,
with emphasis placed on the Company’s late-stage product
opportunities and new product launches.
The meeting will be webcast live on the investor relations
section of the Forest Laboratories website at www.frx.com. A link
to access the webcast will become available on the Forest website
later in May.
About Forest
Laboratories
Forest Laboratories’ (NYSE: FRX) longstanding global
partnerships and track record developing and marketing
pharmaceutical products in the United States have yielded its
well-established central nervous system and cardiovascular
franchises and innovations in anti-infective and respiratory
medicine. The Company’s pipeline, the most robust in its history,
includes product candidates in all stages of development across a
wide range of therapeutic areas. The Company is headquartered in
New York, NY. To learn more, visit www.FRX.com.
Except for the historical information contained herein, this
release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
statements involve a number of risks and uncertainties, including
the difficulty of predicting FDA approvals, the acceptance and
demand for new pharmaceutical products, the impact of competitive
products and pricing, the timely development and launch of new
products, and the risk factors listed from time to time in Forest
Laboratories’ Annual Reports on Form 10-K, Quarterly Reports on
Form 10-Q, and any subsequent SEC filings.
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Aug 2023 to Aug 2024
